Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Kinoshita

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical Calcium|March 25, 2017
[The functions of calcium-sensing receptor in regulating mineral metabolism.]Yuka Kinoshita
Clinical Calcium|January 28, 2016
[Inhitibion of FGF23 activities as a possible new treatment for patients with FGF23-related hypophosphatemic diseases]Yuka Kinoshita
Clinical Calcium|June 29, 2018
[Body weight and bone/calcium metabolism. The effect of incretin hormones on bone and calcium metabolism.]Yuka Kinoshita
Clinical Calcium|October 1, 2018
[Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.]Yuka Kinoshita
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 5, 2015
[Endocrine disorders and osteoporosis]Yuka Kinoshita
Clinical Calcium|November 29, 2012
[Space flight/bedrest immobilization and bone. Medical treatment for immobilization osteoporosis]Yuka Kinoshita, Seiji Fukumoto
Clinical Calcium|July 29, 2014
[Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia]Yuka Kinoshita, Seiji Fukumoto
Clinical Calcium|February 29, 2012
[Parathyroid hormone for disorders of calcium metabolism and metabolic bone diseases other than osteoporosis]Yuka Kinoshita, Seiji Fukumoto
Clinical Calcium|May 31, 2013
[Antagonists of Wnt pathway]Yuka Kinoshita, Seiji Fukumoto
Endocrine Reviews|January 31, 2018
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New TreatmentYuka Kinoshita, Seiji Fukumoto
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical Calcium|March 25, 2017
[The functions of calcium-sensing receptor in regulating mineral metabolism.]Yuka Kinoshita
Clinical Calcium|January 28, 2016
[Inhitibion of FGF23 activities as a possible new treatment for patients with FGF23-related hypophosphatemic diseases]Yuka Kinoshita
Clinical Calcium|June 29, 2018
[Body weight and bone/calcium metabolism. The effect of incretin hormones on bone and calcium metabolism.]Yuka Kinoshita
Clinical Calcium|October 1, 2018
[Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.]Yuka Kinoshita
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 5, 2015
[Endocrine disorders and osteoporosis]Yuka Kinoshita
Clinical Calcium|November 29, 2012
[Space flight/bedrest immobilization and bone. Medical treatment for immobilization osteoporosis]Yuka Kinoshita, Seiji Fukumoto
Clinical Calcium|July 29, 2014
[Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia]Yuka Kinoshita, Seiji Fukumoto
Clinical Calcium|February 29, 2012
[Parathyroid hormone for disorders of calcium metabolism and metabolic bone diseases other than osteoporosis]Yuka Kinoshita, Seiji Fukumoto
Clinical Calcium|May 31, 2013
[Antagonists of Wnt pathway]Yuka Kinoshita, Seiji Fukumoto
Endocrine Reviews|January 31, 2018
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New TreatmentYuka Kinoshita, Seiji Fukumoto
Pageof 5